Literature DB >> 429516

Increased ratio between changes in blood pressure and plasma norepinephrine in essential hypertension.

P Weidmann, G Keusch, J Flammer, W H Ziegler, F C Reubi.   

Abstract

The pathogenic role of the sympathetic system in essential hypertension was evaluated by combined analysis of plasma catecholamine levels and the pressor sensitivity to endogenous norepinephrine. The latter was estimated indirectly by the ratio between changes in blood pressure and those in plasma norepinephrine after adrenergic neuronal blockage with debrisoquine (given orally for 6 weeks). Normal subjects and patients with borderline or established essential hypertension had comparable pretreatment levels of plasma norepinephrine and epinephrine. Debrisoquine lowered plasma norepinephrine by a similar degree (almost 50%) in these three groups; in contrast, blood pressure decreased only slightly in normal or borderline hypertensive subjects [-3.4 +/- 3.2% and -5.4 +/- 1.6% (SE), respectively] but fell significantly more (P less than 0.005) in patients with established essential hypertension (-20.7 +/- 3.9%). The ratio between percentile changes in blood pressure and those in endogenous norepinephrine levels was comparable in normal and borderline hypertensive subjects (0.03 +/- 0.08 and 0.17 +/- 0.04, respectively), but increased (P less than 0.001) in established essential hypertension (0.62 +/- 0.11). This suggests that essential hypertension may be maintained, at least partly, by the inappropriate association of normal plasma norepinephrine levels with increased norepinephrine pressor sensitivity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429516     DOI: 10.1210/jcem-48-5-727

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

2.  Association between sympathetic activity and the atherogenic serum cholesterol fraction.

Authors:  P Weidmann; D C Schohn; W Riesen; H A Jahn; P Ferrari; S G Shaw; C Beretta-Piccoli
Journal:  Klin Wochenschr       Date:  1990-03-05

Review 3.  Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects.

Authors:  M G Bianchetti; I Minder; C Beretta-Piccoli; A Meier; P Weidmann
Journal:  Klin Wochenschr       Date:  1982-05-03

4.  Norepinephrine clearance and pressor effect in normal and hypertensive man.

Authors:  M Grimm; P Weidmann; G Keusch; A Meier; Z Glück
Journal:  Klin Wochenschr       Date:  1980-11-03

5.  Disturbed noradrenergic blood pressure control in normotensive members of hypertensive families.

Authors:  M G Bianchetti; P Weidmann; C Beretta-Piccoli; U Rupp; K Boehringer; L Link; C Ferrier
Journal:  Br Heart J       Date:  1984-03

6.  Calcitonin gene-related peptide (CGRP) in autonomic cardiovascular regulation and vascular structure.

Authors:  Tu H Mai; Jing Wu; André Diedrich; Emily M Garland; David Robertson
Journal:  J Am Soc Hypertens       Date:  2014-03-13

7.  Correction of altered noradrenaline reactivity in essential hypertension by indapamide.

Authors:  M Grimm; P Weidmann; A Meier; G Keusch; W Ziegler; Z Glück; C Beretta-Piccoli
Journal:  Br Heart J       Date:  1981-10

8.  Cardiovascular regulation during administration of co-dergocrine to normal subjects.

Authors:  A Gerber; P Weidmann; K Laederach
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Clonidine induced variations of plasma norepinephrine and blood pressure in essential hypertension.

Authors:  S S Lee; H Kim; Y C Park; J H Song; M H Lee; E S Chung; S J Lee; C W Imm
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.